115 related articles for article (PubMed ID: 37913914)
21. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.
Ding J; Qin D; Zhang Y; Li Q; Li Y; Li J
Mol Med Rep; 2020 Mar; 21(3):1251-1257. PubMed ID: 31922244
[TBL] [Abstract][Full Text] [Related]
22. [The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].
Bi MH; Wang BE; Zheng XX; Li M; Mayer K; Zhang SW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):461-4. PubMed ID: 18687171
[TBL] [Abstract][Full Text] [Related]
23. Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice.
Wu YX; He HQ; Nie YJ; Ding YH; Sun L; Qian F
Acta Pharmacol Sin; 2018 Jan; 39(1):85-96. PubMed ID: 29047459
[TBL] [Abstract][Full Text] [Related]
24. Protective Effect of Colchicine on LPS-Induced Lung Injury in Rats via Inhibition of P-38, ERK1/2, and JNK Activation.
Yue Q; Liu T; Cheng Z
Pharmacology; 2020; 105(11-12):639-644. PubMed ID: 32688359
[TBL] [Abstract][Full Text] [Related]
25. SZ168 treats LPS-induced acute lung injury by inhibiting the activation of NF-κB and MAPKs pathways.
Heng J; Wu D; Zhao Y; Lu S
Respir Physiol Neurobiol; 2023 Jan; 307():103965. PubMed ID: 36150645
[TBL] [Abstract][Full Text] [Related]
26. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice.
He Y; Zhao Y; Feng Y; Ren A; Zhang Y; Wang Y; Li H
Eur J Pharmacol; 2020 Feb; 869():172893. PubMed ID: 31883915
[TBL] [Abstract][Full Text] [Related]
28. Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways.
Yan LS; Cui S; Cheng BC; Yin XB; Wang YW; Qiu XY; Nima CR; Zhang Y; Zhang SF
Drug Des Devel Ther; 2023; 17():297-312. PubMed ID: 36756190
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway.
Liu Z; Huang X; Guo HY; Zhang LW; Quan YS; Chen FE; Shen QK; Quan ZS
Eur J Med Chem; 2023 Nov; 259():115697. PubMed ID: 37544187
[TBL] [Abstract][Full Text] [Related]
30. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
[TBL] [Abstract][Full Text] [Related]
31. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Yu X; Yu S; Chen L; Liu H; Zhang J; Ge H; Zhang Y; Yu B; Kou J
Biomed Pharmacother; 2016 Aug; 82():489-97. PubMed ID: 27470389
[TBL] [Abstract][Full Text] [Related]
32. Modulation of LPS-stimulated pulmonary inflammation by Borneol in murine acute lung injury model.
Zhong W; Cui Y; Yu Q; Xie X; Liu Y; Wei M; Ci X; Peng L
Inflammation; 2014 Aug; 37(4):1148-57. PubMed ID: 24566873
[TBL] [Abstract][Full Text] [Related]
33. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of abamectin on acute lung injury induced by lipopolysaccharide in mice.
Zhang X; Li J; Chen C; Ci X; Yu Q; Zhang X; Deng X
Fundam Clin Pharmacol; 2011 Dec; 25(6):700-7. PubMed ID: 21118302
[TBL] [Abstract][Full Text] [Related]
35. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
Liu XX; Yu DD; Chen MJ; Sun T; Li G; Huang WJ; Nie H; Wang C; Zhang YX; Gong Q; Ren BX
Int Immunopharmacol; 2015 Apr; 25(2):370-6. PubMed ID: 25724384
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
37. Sangxingtang inhibits the inflammation of LPS-induced acute lung injury in mice by down-regulating the MAPK/NF-κB pathway.
Zhang TZ; Yang SH; Yao JF; Du J; Yan TH
Chin J Nat Med; 2015 Dec; 13(12):889-95. PubMed ID: 26721707
[TBL] [Abstract][Full Text] [Related]
38. Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury.
Liang Y; Luo J; Yang N; Wang S; Ye M; Pan G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32091104
[TBL] [Abstract][Full Text] [Related]
39. Cardamine komarovii flower extract reduces lipopolysaccharide-induced acute lung injury by inhibiting MyD88/TRIF signaling pathways.
Chen Q; Zhang KX; Li TY; Piao XM; Lian ML; An RB; Jiang J
Chin J Nat Med; 2019 Jun; 17(6):461-468. PubMed ID: 31262458
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects.
Tian Y; Zhu CL; Li P; Li HR; Liu Q; Deng XM; Wang JF
J Surg Res; 2023 Mar; 283():9-18. PubMed ID: 36347171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
